Have a feature idea you'd love to see implemented?
Let us know!
ANGO Angiodynamics Inc
Price (delayed)
$6.94
Market cap
$282M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$6.03
Enterprise value
$227M
AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics' diverse product lines include
Highlights
Angiodynamics's equity has plunged by 54% YoY and by 4.4% from the previous quarter
The quick ratio has decreased by 34% YoY and by 6% QoQ
Key stats
What are the main financial stats of ANGO
Market
Valuations
Earnings
Shares outstanding
40.63M
Market cap
$282M
Enterprise value
$227M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.42
Price to sales (P/S)
0.96
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.78
Revenue
$292.73M
EBIT
-$240.66M
EBITDA
-$210.9M
Free cash flow
$5.61M
Per share
Balance sheet
Liquidity
EPS
-$6.03
Free cash flow per share
$0.14
Book value per share
$4.88
Revenue per share
$7.2
TBVPS
$5.36
Total assets
$293.63M
Total liabilities
$97.05M
Debt
$0
Equity
$196.58M
Working capital
$95.9M
Debt to equity
0
Current ratio
2.25
Quick ratio
1.23
Net debt/EBITDA
0.26
Margins
Efficiency
Dividend
EBITDA margin
-72%
Gross margin
51.7%
Net margin
-83%
Operating margin
-82.2%
Return on assets
-67.7%
Return on equity
-95.1%
Return on invested capital
-286.7%
Return on capital employed
-110.9%
Return on sales
-82.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ANGO stock price
How has the Angiodynamics stock price performed over time
Intraday
0%
1 week
-2.8%
1 month
-10.8%
1 year
9.46%
YTD
-11.48%
QTD
-10.8%
Financial performance
How have Angiodynamics's revenue and profit performed over time
Revenue
$292.73M
Gross profit
$151.36M
Operating income
-$240.74M
Net income
-$243.03M
Gross margin
51.7%
Net margin
-83%
The company's net margin fell by 37% QoQ
ANGO's net income is down by 32% since the previous quarter
The company's operating margin fell by 30% QoQ
ANGO's operating income is down by 25% since the previous quarter
Growth
What is Angiodynamics's growth rate over time
Valuation
What is Angiodynamics stock price valuation
P/E
N/A
P/B
1.42
P/S
0.96
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.78
Angiodynamics's EPS has decreased by 31% from the previous quarter
Angiodynamics's equity has plunged by 54% YoY and by 4.4% from the previous quarter
The P/B is 29% more than the last 4 quarters average of 1.1
The P/S is 49% less than the 5-year quarterly average of 1.9 but 20% more than the last 4 quarters average of 0.8
The revenue has declined by 13% year-on-year and by 3.7% since the previous quarter
Efficiency
How efficient is Angiodynamics business performance
The ROE has dropped by 62% since the previous quarter
ANGO's ROA has dropped by 50% since the previous quarter
ANGO's ROIC is down by 35% QoQ
Angiodynamics's ROS has decreased by 29% from the previous quarter
Dividends
What is ANGO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ANGO.
Financial health
How did Angiodynamics financials performed over time
The company's total liabilities rose by 47% YoY but it fell by 13% QoQ
Angiodynamics's total assets has decreased by 41% YoY and by 8% QoQ
The company's debt is 100% lower than its equity
Angiodynamics's equity has plunged by 54% YoY and by 4.4% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.